Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Apr 10 2025 | A Novel Congestion Index for Heart Failure and the Impact of Social Isolation Among Older Adults with Advanced Heart Failure Highlighted in the April 2025 Issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More Apr 9 2025 | Journal of Cardiac Failure Call for Papers: Focus Issue on Hemodynamics HFSA News Journal of Cardiac Failure Read More Apr 8 2025 | Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study Industry News In The News Industry Read More Apr 7 2025 | HFSA Awards: Nominations Now Open through May 2, 2025 HFSA News Awards Read More Apr 6 2025 | HFSA President's Update: April 2025 HFSA News President's Updates Read More Pagination First page « First Previous page ‹ Previous … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 … Next page Next › Last page Last »
Apr 10 2025 | A Novel Congestion Index for Heart Failure and the Impact of Social Isolation Among Older Adults with Advanced Heart Failure Highlighted in the April 2025 Issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More
Apr 9 2025 | Journal of Cardiac Failure Call for Papers: Focus Issue on Hemodynamics HFSA News Journal of Cardiac Failure Read More
Apr 8 2025 | Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study Industry News In The News Industry Read More
